| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |